Top Story

Stair climbing after meal decreases postprandial blood glucose in type 2 diabetes

July 26, 2016

In older adults with type 2 diabetes, 3 minutes of stair climbing 1 and 2 hours after a meal decreased postprandial blood glucose levels, according to recent findings.

In a crossover-design study, Hiroto Honda, of Toyooka Hospital Hidaka Medical Center, Japan, and colleagues analyzed data from 16 adults with type 2 diabetes who regularly visited Toyooka Hospital Hidaka Medical Center (13 men; mean age, 65 years; mean BMI, 23.6 kg/m²; mean HbA1c, 6.9%; mean diabetes duration, 11.3 years). All participants were free of microvascular or macrovascular complications and were already under medical nutritional therapy and exercise therapy (discontinued on experimental days). Participants reported not regularly climbing stairs in their daily lives.

Iron deficiency seen with thyroid disorders during pregnancy

July 26, 2016
Iron deficiency during the first trimester of pregnancy is common and associated with a higher prevalence of thyroid autoimmunity and higher thyroid-stimulating hormone…

Higher osteoprotegerin levels associated with foot ulcer in type 1 diabetes

July 26, 2016
In patients with type 1 diabetes, higher levels of the glycoprotein osteoprotegerin are associated with development of a foot ulcer, independent of other well-known risk…

Food cue response continues after meal in women with obesity

July 26, 2016
In women with severe obesity, the brain’s reward centers continue to respond to food cues even after meals, according to researchers. “Before or after the…

Omega-3 fatty acid supplementation does not affect insulin resistance in PCOS

July 25, 2016
Women with polycystic ovary syndrome likely receive no benefit from daily omega-3 fatty acid supplementation, according to a meta-analysis of three randomized controlled…
More News Headlines »

Diabetic Eye 2015: New Concepts in Screening, Managing, and Referral

This activity is supported by an educational grant from Allergan, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Meeting News Coverage

VIDEO: SGLT2 inhibitor slows renal decline independent of glucose control

June 12, 2016
More »
Highlights from ADA

Highlights from ADA

CME Video

Managing Today's EP Challenges with NOAC Use

This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.

This engaging activity featuring a superb faculty provides electrophysiologists and others with the best information…
More »
Current Issues
View the Current Issues